Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000242134 | SCV000302187 | likely benign | not specified | criteria provided, single submitter | clinical testing | ||
Gene |
RCV000242134 | SCV000522991 | likely benign | not specified | 2016-01-11 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV002055023 | SCV002467479 | benign | Ehlers-Danlos syndrome, classic type, 1 | 2024-01-18 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002055023 | SCV002554211 | benign | Ehlers-Danlos syndrome, classic type, 1 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002270111 | SCV002554212 | benign | Fibromuscular dysplasia, multifocal | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000242134 | SCV004038859 | benign | not specified | 2023-08-10 | criteria provided, single submitter | clinical testing |